Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Akebia Therapeutics
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male and female subjects between 18 and 55 years of age, inclusive, and with a body mass index between 18 and 30 kg/m2, inclusive.
You may not be if
Current or past history of cardiovascular, cerebrovascular, pulmonary, renal or liver disease.
Positive serology results for HBsAg, HCV, and HIV at Screening.
Significant renal impairment as evidenced by an estimated glomerular filtration rate (eGFR) of \<65 mL/min
Known active cancer (except non-melanoma skin cancer) or history of chemotherapy use within the previous 24 months.
Current or past history of gastric or duodenal ulcers or other diseases of the GI tract (including gastric bypass surgeries) that could interfere with absorption of study drug.
Subjects with a known history of smoking and/or have used nicotine or nicotine-containing products within the past 6 months.
Clareo Health | Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects
